QIAGEN N.V.

About QIAGEN N.V.

QIAGEN is a global provider of sample-to-insight solutions, focusing on enabling customers to gain valuable molecular insights from samples. Their mission is to make improvements in life possible by offering tools and technologies for research, diagnostics, and clinical applications.

Products & Services

QIAcuityDx:A fully automated digital PCR system for IVD applications, enhancing diagnostic precision and operational efficiency.

QIAwave Kits:Eco-friendly nucleic acid extraction kits available in 50 and 250 sample sizes, using less plastic and cardboard.

Proteinase K and Proteinase K Ultrapure:Enzymes for efficient protein digestion in biological samples and DNA/RNA preparation.

TissueLyser III:An instrument for effective lysis of challenging samples for downstream DNA and RNA analysis.

QIAseq xHYB Viral and Bacterial Panels:Targeted NGS panels for high-sensitivity detection and sequencing of viral and bacterial pathogens.

QIAseq FastSelect RNA Library Kits:Solutions for fast RNA-seq library preparation with rRNA removal in under 5 hours.

QIAstat-Dx Viral Vesicular Panel:A panel for research and surveillance of mpox and other viral pathogens with seven targets.

QIAxcel Connect System:A gel electrophoresis system for high-resolution analysis of up to 96 samples in a single run.

QIAcuity dPCR System:A fast, accessible, and reliable digital PCR system delivering results in two hours.

QuantiFERON-TB Gold Plus:A diagnostic tool for tuberculosis management.

QIAstat-Dx Syndromic Testing:A system for rapid molecular diagnostics in infectious disease testing.

therascreen Solid Tumor:A diagnostic tool for oncology focusing on solid tumors.

Specialties

Molecular Diagnostics Digital PCR Next-Generation Sequencing Sample Preparation Infectious Disease Testing Oncology Tuberculosis Management Transplant Diagnostics Human ID & Forensics Microbiome Research Cancer Research Informatics and Data Analysis

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Convertible Debt T: - FT: Convertible Debt	A: 750000000 MR: - FA: 750 million FAN: 750000000	D: 2025-08-28 FD: 2025-08-28	-

Convertible Debt Latest

2025-08-28

$750.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

QIAGEN N.V. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised